PURPOSEGEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment ...

The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the ...

The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

"PanTher Therapeutics launches second trial for chemotherapy patch" was originally created and published by Clinical Trials ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

Immunotherapy has been an unsuccessful strategy in the treatment of hormone receptor–positive, HER2-negative breast cancer. Pelareorep (Pel), an oncolytic reovirus, improved overall survival when ...

Is transarterial (chemo)embolisation better than systemic chemotherapy for treating bowel cancer that has spread to the liver?

Paclitaxel (PTX) has emerged as one of the first-line drug candidates in cancer therapy due to its potency and profound anticancer potential. Derived from a rich natural source, it stands out as a ...

Researchers in Japan created an AI that can detect fatty liver disease from ordinary chest X-rays—an unexpected and low-cost method that could transform early diagnosis. The model proved highly ...

The toxic fungus Aspergillus flavus—known as the “Pharaoh’s Curse” due to its role in the deaths of archaeologists who opened the Tomb of Tutankhamun in the 1920s—could have cancer ...

Find out about possible causes of cancer, how cancer starts and grows, tests to diagnose it, and general information about treatments.